barkan management company, inc.

24 farnsworth street
boston, massachusetts 02210

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 28, 2013

NYS DOS ID#
4424288

County
NEW YORK

Jurisdiction
MASSACHUSETTS

Registered Agent
NONE

NYS Entity Type
FOREIGN BUSINESS CORPORATION

Name History
2013 - BARKAN MANAGEMENT COMPANY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • At Walmart Academy, Training Better Managers. But With a Better Future?
    By MICHAEL CORKERY - Tuesday Aug 8, 2017

    A new program for store supervisors and department managers may make them better employees but may not help them reach the middle class.

    Source: NYT > Home Page
  • Growth Is the New HP Way, for Now
    Thursday Aug 24, 2017

    What to do with a no-growth technology company that actually manages to grow? That is the conundrum facing HP Inc.’s investors.

    Source: The Wall Street Journal: Markets News
  • CarGurus Drives Off With $150M in Boston’s First Tech IPO of 2017
    By Jeff Engel - Thursday Oct 12, 2017

    [Updated 10/12/17, 10:20 am. See below.] Amid another sluggish year for tech IPOs, advocates of Boston’s tech scene can breathe a sigh of relief—the area won’t be shut out this year. CarGurus and its stockholders raised about $150.4 million in the company’s initial public offering, marking the Boston area’s first tech IPO of 2017. The Cambridge, […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Economic Trends: To Understand Rising Inequality, Consider the Janitors at Two Top Companies, Then and Now
    By NEIL IRWIN - Sunday Sep 3, 2017

    Focusing on core competence and outsourcing the rest has made U.S. companies lean, nimble and productive. It has also left lots of people worse off.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed